Volver a la clasificación

Philip Morris International Inc (PM)

Valor Justo
Consumer DefensiveTobaccoUnited States

Fundamental

74

Precio

$190.82

Capitalización Bursátil

$302.00B

Parte 1 · Cuánto vale la empresa

Resumen

Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Balance y Liquidez

Ingresos

$42.55B

Últimos 12 meses (hasta 30/6/2026)

Beneficio Neto

$10.87B

Últimos 12 meses (hasta 30/6/2026)

Flujo de Caja Libre

$10.66B

Patrimonio Neto Total

$-9.99B

Pasivo Total

$77.21B

Ratio de Liquidez

0.98

Cobertura de Intereses

9.38

Deuda/EBITDA

2.91

Beneficio Por Acción

Ingresos y Beneficio Neto

Flujo de Caja Libre

Desglose de Ingresos

Estado histórico

Márgenes en el tiempo

La deuda en el tiempo

Cuánto pesa la deuda

Cuadro de crecimiento

Crecimiento — Ingresos

Estimación de Valor Justo

Caso generalValoración Justa

Valor Justo

$172.27

Precio Actual

$190.82

Margen de Seguridad

-10.8%

Rango de Valor Justo

$140.86 - $203.69

Dispersión entre los métodos de valoración utilizados, no un intervalo de confianza calibrado estadísticamente.

Métodos de Estimación

Precio objetivo de los analistas:$208.13
Flujo de caja descontado (DCF):$174.96
Múltiplo sobre beneficios (P/E):$154.24
Fórmula de crecimiento de Graham:$145.50
Valor de la capacidad de generar beneficios (EPV):$101.67
P/B justificado:$18.96
Descuento de dividendos (Gordon):$144.13
P/FFO, fondos de operaciones:$136.98
Beneficios de mitad de ciclo:$149.98
Múltiplo sobre ingresos:$32.31
Consenso de Analistas:Compra Fuerte (20B / 7H / 0S)
Última Sorpresa de Resultados:+4.38%

Métricas de Valoración

Ratio P/E

27.46

ROE

-113.5%

Ratio P/B

-

P/FCF

23.38

Margen Bruto

67.5%

ROIC

30.4%

Radar de Rentabilidad

Creación de Valor (Ventaja Competitiva)

ROIC

30.4%

WACC

7.2%

ROIC − WACC

+23.2 pp

El ROIC supera el coste del capital: la empresa está creando valor para los accionistas.

Criterios de Análisis Fundamental

Superado (20)

  • EPS shows upward trend
  • EPS CAGR 5.31%
  • Price CAGR 7.64%
  • ROIC 30.4%
  • Gross Margin 67.5%
  • P/FCF 23.38
  • Operating Margin 37.7%
  • Positive Free Cash Flow
  • CapEx intensity
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 575.4%
  • Revenue Growth 5Y 7.2%
  • Analyst Consensus 74% Buy
  • Earnings Quality (OCF/NI) 1.31
  • Share Dilution 0.1%
  • Net Margin Trend 25.6% vs 21.1%
  • Piotroski F-Score 8/9

Fallido (4)

  • Low reliance on intangibles
  • DCF valuation (Overvalued)
  • Earnings Surprise avg 2.2%
  • PEG Ratio 3.92

No disponible (4)

  • P/B Ratio NaN
  • Dividend Payout NaN%
  • Debt/Equity ratio
  • Price below Graham Number

Piotroski F-Score

8/9

Solidez financiera fuerte

score
criteria

Calidad de los Beneficios

1.31

Alta calidad: beneficios respaldados por efectivo

Dilución de Acciones

0.1%

El número de acciones es estable

Participaciones institucionales

Gobernanza

Equipo Directivo

NombreCargoEdad
Mr. Jacek OlczakGroup CEO & Director60
Mr. Massimo AndolinaGroup Chief Financial Officer56
Mr. Frederic de WildeCEO of PMI International58
Ms. Stacey KennedyCEO of PMI U.S.52
Mr. Emmanuel BabeauStrategic Advisor58
Mr. Scott CouttsChief Global Operations Officer-
Mr. Michael VoegeleChief Digital & Information Officer51
Mr. James R. BushnellVice President of Investor Relations & Financial Communications-
Mr. Yann GuerinGroup Chief Legal Officer48
Dr. Moira GilchristChief Communications Officer-

Riesgo de Auditoría

2

Riesgo del Consejo

5

Riesgo de Compensación

1

Riesgo de Derechos del Accionista

5

Parte 2 · El precio y el momento de entrar

Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.

Documentos

  • Informe anual (10-K)

    Un resumen anual del negocio, los resultados financieros y los riesgos de la empresa.

    Presentado el 2026-02-06

    Ver documento
  • Informe trimestral (10-Q)

    Una actualización del desempeño financiero de los últimos tres meses.

    Presentado el 2026-07-24

    Ver documento
  • Informe de hecho relevante (8-K)

    Un aviso sobre un hecho relevante, como un cambio de dirección o un anuncio importante.

    Presentado el 2026-09-18

    Ver documento

via SEC EDGAR

Historial de Resultados

via SEC EDGAR

Latest News

Recent headlines for PM, sourced from Markets Gazette.

  • 21d agoPOSITIVE
    Philip Morris CEO Is ‘Optimistic’ About Zyn Potential

    Philip Morris International CEO Jacek Olczak expressed optimism regarding the growth potential of Zyn, a nicotine pouch product. He highlighted strong demand and discussed the company's year-end market share targets for Zyn. The potential introduction of larger cans, containing 15 to 20 pouches, was also explored as a strategy to enhance revenue and profit margins. This positive outlook on Zyn's performance and strategic expansion could signal continued growth for Philip Morris International, potentially influencing investor sentiment positively.

  • 6/2/2026NEGATIVE
    Philip Morris Cuts Outlook on $500 Million Canada Writedown

    Philip Morris International Inc. has revised its full-year profit forecast downwards, citing a substantial $500 million writedown on its investment in its Canadian affiliate. This significant impairment charge indicates potential underperformance or strategic challenges within its Canadian operations. Investors will be closely monitoring the company's ability to navigate these issues and recover profitability. The writedown raises concerns about the company's international segment performance and could lead to a reassessment of its growth trajectory and risk factors.

  • 4/22/2026POSITIVE
    What's Going On With Philip Morris Stock Today?

    Philip Morris International Inc. (PM) shares surged following a robust earnings report that surpassed analyst expectations. The company's performance was primarily fueled by significant growth in its smoke-free product category, which continues to offset challenges elsewhere. Despite this strong quarterly showing, Philip Morris has slightly lowered its full-year earnings guidance, a move that may temper some of the immediate enthusiasm. However, the core strength in its next-generation products signals a successful transition strategy, offering a positive outlook for long-term investors focused on the company's evolving portfolio.

  • 4/1/2026NEGATIVE
    Philip Morris Stock Falls As Zyn Delays Threaten Major Growth Engine

    Philip Morris International (PM) saw its stock price decline following reports that the FDA's expedited review process for new nicotine pouch applications has been delayed. This slowdown directly impacts the growth trajectory of Zyn, a key product for the company's future revenue streams. The delay raises concerns about the pace of market expansion and regulatory hurdles, potentially affecting investor confidence in PM's ability to capitalize on the burgeoning oral nicotine market. Investors are closely watching for further updates on the regulatory timeline and its impact on Zyn's sales projections.

  • 3/8/2026POSITIVE
    Philip Morris CEO Says Cigarettes Belong in a Museum as Zyn and IQOS Surge

    Philip Morris International is accelerating its transition from traditional cigarettes to smoke-free alternatives like IQOS and Zyn, a strategic shift aimed at reducing harm by eliminating combustion. The company's CEO suggests cigarettes should eventually be phased out. This pivot is driven by the surging popularity of nicotine pouches and heated tobacco products. While public health experts raise concerns about long-term effects and persistent addiction risks, the company's focus on innovation and market adaptation in a heavily regulated industry signals a potentially strong future performance for investors.

  • 2/24/2026NEUTRAL
    Here's How Much $100 Invested In Philip Morris Intl 5 Years Ago Would Be Worth Today

    A retrospective analysis of an investment in Philip Morris International offers crucial insights for long-term investors. While the headline doesn't provide specific details on the exact value of $100 invested five years ago, the significance of such studies lies in their ability to assess a company's historical performance. For investors, understanding how a stock has performed over time, including dividends and capital appreciation, is fundamental for shaping future expectations and refining portfolio strategies. Philip Morris, a tobacco giant with a growing emphasis on smoke-free products, represents an interesting case of market transition. Historical analysis helps contextualize the company's resilience and adaptability in the face of regulatory challenges and changing consumer habits, providing a basis for informed decisions.

  • 2/24/2026POSITIVE
    Inside a $280 billion tobacco giant’s push to turn smokers into smoke-free customers

    Philip Morris International, the $280 billion tobacco giant, is charting an ambitious course towards a smoke-free future. The company's core strategy involves transitioning traditional cigarette smokers to smoke-free product alternatives, a critical move to adapt to an evolving regulatory and health landscape. This strategic pivot is considered vital for the company's long-term sustainability and growth, positioning it to capitalize on emerging trends within the industry. Investors should closely monitor the effectiveness of this transition, as success in the reduced-risk product market could unlock significant future value for the company.

via Markets Gazette